Ditchcarbon
  • Contact
  1. Organizations
  2. AXIM Biotechnologies, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

AXIM Biotechnologies, Inc. Sustainability Profile

Company website

AXIM Biotechnologies, Inc., a leading player in the biotechnology sector, is headquartered in the United States. Founded in 2014, the company has made significant strides in the development of innovative cannabinoid-based products, focusing on areas such as pharmaceuticals, diagnostics, and consumer goods. AXIM is renowned for its unique offerings, including proprietary formulations that leverage the therapeutic potential of cannabinoids. The company’s commitment to research and development has positioned it as a pioneer in the industry, with notable achievements in clinical trials and product launches. With a strong market presence, AXIM Biotechnologies continues to drive advancements in cannabinoid science, aiming to improve health outcomes and enhance quality of life for patients worldwide.

DitchCarbon Score

How does AXIM Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

AXIM Biotechnologies, Inc.'s score of 17 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

AXIM Biotechnologies, Inc.'s reported carbon emissions

AXIM Biotechnologies, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. Given the lack of emissions data and formal climate commitments, AXIM Biotechnologies appears to be in the early stages of addressing its carbon footprint and climate impact. As the industry increasingly prioritises sustainability, it may be beneficial for the company to consider setting measurable targets and engaging in climate initiatives to align with best practices in environmental responsibility.

How Carbon Intensive is AXIM Biotechnologies, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. AXIM Biotechnologies, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is AXIM Biotechnologies, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for AXIM Biotechnologies, Inc. is in US, which has a low grid carbon intensity relative to other regions.

AXIM Biotechnologies, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

AXIM Biotechnologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare AXIM Biotechnologies, Inc.'s Emissions with Industry Peers

Cronos Group Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Aurora Cannabis Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

INSYS Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Tilray Brands, Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Verano Holdings Corp.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Trulieve Cannabis Corp.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy